Tierarztl Prax Ausg K Kleintiere Heimtiere 2007; 35(04): 302-308
DOI: 10.1055/s-0038-1622633
Für Studium und Praxis
Schattauer GmbH

Immunvermittelte hämolytische Anämie beim Hund: Pathophysiologie, klinische Symptome und Diagnose

A. Balch
1   Las Vegas Veterinary Referral Center, Nevada, USA
,
A. Mackin
2   College of Veterinary Medicine, Mississippi State University, USA
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
09. Januar 2018 (online)

 

Modifizierter Nachdruck. Quelle: Compendium on Continuing Education for the Practicing Veterinarian, Veterinary Learning Systems, Yardley, Pennsylvania, USA


 
  • Literaturf

  • 1 Jain NC. Hemolytic anemia of noninfectious origin. In Schalm’s Veterinary Hematology. Philadelphia: Lea & Febiger; 1986: 647-651.
  • 2 Weiser MG. Erythrocyte responses and disorders. In: Textbook of Veterinary Internal Medicine ed. 4.. Ettinger SJ, Feldman EC. eds St. Louis: Saunders; 1995: 1864-1891.
  • 3 Bennett D, Finnett SL, Nash AS. et al Primary autoimmune hemolytic anemia in the dog. Vet Rec 1981; 109 (08) 150-153.
  • 4 Burgess K, Moore A, Rand W. et al Treatment of immune-mediated hemolytic anemia in dogs with cyclophosphamide. J Vet Intern Med 2000; 14 (04) 456-462.
  • 5 Klag A, Giger U, Shofer F. Idiopathic immunemediated hemolytic anemia in dogs: 42 cases (1986–1990). JAVMA 1993; 202 (05) 783-788.
  • 6 Mason N, Duval D, Shofer FS. et al Cyclophosphamide exerts no beneficial effect over prednisone alone in the initial treatment of acute immune mediated hemolytic anemia in dogs: A randomized controlled clinical trial. J Vet Intern Med 2003; 17 (02) 206-212.
  • 7 Giger U. Regenerative anemias caused by blood loss or hemolysis. In: Textbook of Veterinary Internal Medicine ed. 5.. Ettinger SJ, Feldman EC. eds St Louis: Saunders; 2000: 1784-1804.
  • 8 Cotter SM. Hematology. Jackson, WY: Teton NewMedia; 2001: 497-595.
  • 9 Jackson M, Kruth S. Immune-mediated hemolytic anemia and thrombocytopenia in the dog: A retrospective study of 55 cases diagnosed from 1969 through 1983 at the Western College of Veterinary Medicine. Can Vet J 1985; 26: 245-250.
  • 10 Giger U. Regenerative anemias caused by blood loss or hemolysis. In: Textbook of Veterinary Internal Medicine ed. 6.. Ettinger SJ, Feldman EC. eds St Louis: Saunders; 2005: 1886-1907.
  • 11 Barker RN, Elson CJ. Red blood cell glycophorins as B- and T-cell antigens in canine autoimmune hemolytic anemia. Vet Immunol Immunopathol 1995; 47 (03) (04) 225-238.
  • 12 Stewart A, Feldman B. Immune-mediated hemolytic anemia, part I: An overview. Comp Cont Educ Pract Vet 1996; 15 (03) 372-381.
  • 13 Lobetti R, Schoeman T. Immune-mediated hemolytic anaemia: Possible association with An cylostoma caninum infection in three dogs. J S Afr Vet Assoc 2001; 72 (01) 52-54.
  • 14 Duval D, Giger U. Vaccine associated immune mediated hemolytic anemia in the dog. J Vet Intern Med 1996; 10 (05) 290-295.
  • 15 Weinkle TK, Center SA, Randolph JF. et al Evaluation of prognostic factors, survival rates, and treatment protocols for immune-mediated hemolytic anemia in dogs: 151 cases (1993–2002). JAVMA 2005; 226 (11) 1869-1880.
  • 16 Carr AP, Panciera DL, Kidd L. Prognostic factors for mortality and thromboembolism in canine immune-mediated hemolytic anemia: A retrospective study of 72 cases. J Vet Intern Med 2002; 16 (05) 504-509.
  • 17 Trepanier LA. Idiosyncratic toxicity associated with potentiated sulfonamides in the dog. J Vet Pharmacol Ther 2004; 27 (03) 129-138.
  • 18 Papich M. Recognizing adverse drug reactions in animals. Proc WVC: 2002b. 2002
  • 19 Schwartz RS, Berkman EM, Silberstein LE. Autoimmune hemolytic anemias. In: Hematology: Basic Principles and Practice ed. 3.. Hoffman R, Benz EJ, Shattil Jr SJ. et al eds Philadelphia: Churchill Livingstone; 2000: 624
  • 20 Scott-Moncrieff JC, Treadwell NG, McCullough SM. et al Hemostatic abnormalities in anemia. JAAHA 2001; 37 (03) 220-227.
  • 21 Martinez J. Microangiopathic hemolytic anemia. In: Hematology ed. 4.. Williams WJ. ed New York: McGraw-Hill; 1990: 657
  • 22 Giger U. Diagnosis of hemolytic anemias. Proc WSAVA: 2001; 112-113.
  • 23 Noble S, Armstrong J. Bee sting envenomation resulting in secondary immune-mediated hemolytic anemia in two dogs. JAVMA 1999; 214 (07) 1026-1027.
  • 24 Miller SA, Hohenhaus AE, Hale AS. Case-control study of blood type, breed, sex, and bacteremia in dogs with immune-mediated hemolytic anemia. JAVMA 2004; 224 (02) 232-235.
  • 25 Reimer ME, Troy GC, Warnick LD. Immunemediated hemolytic anemia: 70 cases (1988–1996). JAAHA 1999; 35 (05) 384-390.
  • 26 Weiss DJ, Brazzell JL. Detection of activated platelets in dogs with primary immune-mediated hemolytic anemia. J Vet Intern Med 2006; 20 (03) 682-686.
  • 27 Klein MK, Dow S, Rosychuk R. Pulmonary thromboembolism associated with immunemediated hemolytic anemia in dogs: Ten cases (1982–1987). JAVMA 1989; 195 (02) 246-250.
  • 28 Day MJ. Immune-mediated hemolytic anemia. In: Schalm’s Veterinary Hematology Feldman BF, Zinkl JG, Jain NC. eds Philadelphia: Lippincott Williams & Wilkins; 2000: 799-806.
  • 29 Kellerman DL. Heparin therapy: What we do and don’t know. Proc ACVIM: 16: 438-439. 1998;
  • 30 McManus P, Craig L. Correlation between leukocytosis and necropsy findings in dogs with immune mediated hemolytic anemia: 34 cases (1994–1999). JAVMA 2001; 218 (08) 1308-1313.
  • 31 LaRue MJ, Murtaugh RJ. Pulmonary thromboembolism in dogs: 47 cases. JAVMA 1990; 197 (10) 1368-1372.
  • 32 Johnson LR, Lappin MR, Baker DC. Pulmonary thromboembolism in 29 dogs: 1985–1995. J Vet Intern Med 1999; 13 (04) 338-345.
  • 33 Matsumoto AH, Tegtmeyer CJ. Contemporary diagnostic approaches to acute pulmonary emboli. Radiol Clin North Am 1995; 33 (01) 167-183.
  • 34 Weiss DJ, Aird B. Cytologic evaluation of primary and secondary myelodysplastic syndromes in the dog. Vet Clin Pathol 2001; 30 (02) 67-75.
  • 35 Weiss DJ, Smith SA. A retrospective study of 19 cases of canine myelofibrosis. J Vet Intern Med 2002; 16 (02) 174-178.